Search

everythinglearnresearchcommunity

for

Search:↓

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

A new mouse model effectively mimics vitiligo for research and drug testing.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The mesenchymal stem cell-conditioned medium gel improved burn healing and hair growth in rats better than other treatments.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Targeting Vδ1+T-cells may help treat alopecia areata.

Immune system issues may contribute to female pattern hair loss.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Fucoidan reduces bone cell formation by affecting T-cell activity.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.